The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
RETRACTED: Notch-1 induces epithelial–mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells
Open accessAbstract
Activation of Notch-1 is known to be associated with the development and progression of human malignancies including pancreatic cancer. Emerging evidence suggest that the acquisition of epithelial-mesenchymal transition (EMT) phenotype and induction of cancer stem cell (CSC) or cancer stem-like cell phenotype are interrelated and contributes to tumor recurrence and drug resistance. The molecular mechanism(s) by which Notch-1 contributes to the acquisition of EMT phenotype and CSC self-renewal capacity has not been fully elucidated. Here we show that forced over-expression of Notch-1 leads to increased cell growth, clonogenicity, migration and invasion of AsPC-1 cells. Moreover, over-expression of Notch-1 led to the induction of EMT phenotype by activation of mesenchymal cell markers such as ZEB1, CD44, EpCAM, and Hes 1. Here we also report, for the first time, that over-expression of Notch-1 leads to increased expression of miR-21, and decreased expression of miR-200b, miR-200c, let-7a, let-7b, and let-7c. Re-expression of miR-200b led to decreased expression of ZEB1, and vimentin, and increased expression of E-cadherin. Over-expression of Notch-1 also increased the formation of pancreatospheres consistent with expression of CSC surface markers CD44 and EpCAM. Finally, we found that genistein, a known natural anti-tumor agent inhibited cell growth, clonogenicity, migration, invasion, EMT phenotype, formation of pancreatospheres and expression of CD44 and EpCAM. These results suggest that the activation of Notch-1 signaling contributes to the acquisition of EMT phenotype, which is in part mediated through the regulation of miR-200b and CSC self-renewal capacity, and these processes could be attenuated by genistein treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
6 retracted
Ali, S., Ahmad, A., Banerjee, S., Padhye, S., Dominiak, K., Schaffert, J. M., Wang, Z., Philip, P. A., & Sarkar, F. H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4598 · Cited by 424
Self-citationRetractedWang, Z., Zhang, Y., Li, Y., Banerjee, S., Liao, J., & Sarkar, F. H. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0299 · Cited by 314
Self-citationRetractedWang, Z., Li, Y., Banerjee, S., Kong, D., Ahmad, A., Nogueira, V., Hay, N., & Sarkar, F. H. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22451 · Cited by 202
Self-citationRetractedKong, D., Li, Y., Wang, Z., Banerjee, S., & Sarkar, F. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4277 · Cited by 195
Self-citationRetractedWang, Z. P., Zhang, Y., Banerjee, S., Li, Y., & Sarkar, F. H. (2005) · International Journal of Cancer · doi:10.1002/ijc.21589 · Cited by 123
Self-citationRetractedWang, Z. P., Kong, D., Banerjee, S., Li, Y., Adsay, V. N., Abbruzzese, J. L., & Sarkar, F. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2803 · Cited by 117
Self-citationRetractedJemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
Yang, J., & Weinberg, R. A. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.05.009 · Cited by 3,012
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
Singh, A., & Settleman, J. (2010) · Oncogene · doi:10.1038/onc.2010.215 · Cited by 2,545
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,389
Park, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272
Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways
Takebe, N., Harris, P. J., Warren, R. Q., & Ivy, S. P. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.196 · Cited by 992
Edwards, B. K., Brown, M. L., Wingo, P. A., Howe, H. L., Ward, E., Ries, L. A. G., Schrag, D., Jamison, P. M., Jemal, A., Wu, X. C., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji289 · Cited by 952
Reedijk, M., Odorcic, S., Chang, L., Zhang, H., Miller, N., McCready, D. R., Lockwood, G., & Egan, S. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1069 · Cited by 783
MicroRNA expression and function in cancer
Garzon, R., Fabbri, M., Cimmino, A., Calin, G. A., & Croce, C. M. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.10.006 · Cited by 780
Li, Y., VandenBoom, T. G., Kong, D., Wang, Z., Ali, S., Philip, P. A., & Sarkar, F. H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1298 · Cited by 663
Self-citationNotch mediates TGFα-induced changes in epithelial differentiation during pancreatic tumorigenesis
Miyamoto, Y., Maitra, A., Ghosh, B., Zechner, U., Argani, P., Iacobuzio-Donahue, C. A., Sriuranpong, V., Iso, T., Meszoely, I. M., Wolfe, M. S., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00140-5 · Cited by 643
Notch Signaling in Development and Cancer
Bolós, V., Grego-Bessa, J., & de la Pompa, J. L. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0046 · Cited by 545
Notch signaling induces cell cycle arrest in small cell lung cancer cells.
Sriuranpong, V., Borges, M. W., Ravi, R. K., Arnold, D. R., Nelkin, B. D., Baylin, S. B., & Ball, D. W. (2001) · PubMed · Cited by 477
Targeting Notch to Target Cancer Stem Cells
Pannuti, A., Foreman, K., Rizzo, P., Osipo, C., Golde, T., Osborne, B., & Miele, L. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2823 · Cited by 450
Self-citationKong, D., Banerjee, S., Ahmad, A., Li, Y., Wang, Z., Sethi, S., & Sarkar, F. H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012445 · Cited by 411
Self-citationLet-7 and miR-200 microRNAs: Guardians against pluripotency and cancer progression
Peter, M. E. (2009) · Cell Cycle · doi:10.4161/cc.8.6.7907 · Cited by 404
Arslan, A. A. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.63 · Cited by 363
Wnts as ligands: processing, secretion and reception
Mikels, A. J., & Nusse, R. (2006) · Oncogene · doi:10.1038/sj.onc.1210053 · Cited by 356
Wang, Z., Li, Y., Kong, D., & H. Sarkar, F. (2010) · Current Drug Targets · doi:10.2174/138945010791170860 · Cited by 341
Self-citationMiele, L. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2570 · Cited by 317
Self-citationKong, D., Li, Y., Wang, Z., Banerjee, S., Ahmad, A., Kim, H.-R. C., & Sarkar, F. H. (2009) · Stem Cells · doi:10.1002/stem.101 · Cited by 311
Self-citationEmerging role of Notch in stem cells and cancer
Wang, Z., Li, Y., Banerjee, S., & Sarkar, F. H. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.09.030 · Cited by 269
Self-citationAster, J. C., Pear, W. S., & Blacklow, S. C. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.154300 · Cited by 266
Factors influencing myofibroblast differentiation during wound healing and fibrosis.
Desmoulière, A. (1995) · Cell Biology International · doi:10.1006/cbir.1995.1090 · Cited by 265
Arbiter of differentiation and death: Notch signaling meets apoptosis
Miele, L., & Osborne, B. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199912)181:3<393::aid-jcp3>3.0.co;2-6 · Cited by 250
Self-citationTargeting Notch signaling pathway to overcome drug resistance for cancer therapy
Wang, Z., Li, Y., Ahmad, A., Azmi, A. S., Banerjee, S., Kong, D., & Sarkar, F. H. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.06.001 · Cited by 233
Self-citationDynamics of notch expression during murine prostate development and tumorigenesis.
Shou, J., Ross, S., Koeppen, H., de Sauvage, F. J., & Gao, W. (2001) · PubMed · Cited by 223
NOTCH Signaling as a Novel Cancer Therapeutic Target
Miele, L., Miao, H., & Nickoloff, B. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906777441771 · Cited by 201
Self-citationSethi, S. N., Macoska, J. A., Chen, W., & Sarkar, F. H. (2010) · PubMed · Cited by 195
Self-citationCommon Botanical Compounds Inhibit the Hedgehog Signaling Pathway in Prostate Cancer
Ślusarz, A., Shenouda, N. S., Sakla, M. S., Drenkhahn, S. K., Narula, A. S., MacDonald, R. S., Besch-Williford, C. L., & Lubahn, D. B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3012 · Cited by 193
Notch signaling: Its role in epidermal homeostasis and in the pathogenesis of skin diseases
Okuyama, R., Tagami, H., & Aiba, S. (2008) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2007.05.017 · Cited by 167
Schreck, K. C., Taylor, P., Marchionni, L., Gopalakrishnan, V., Bar, E. E., Gaiano, N., & Eberhart, C. G. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1624 · Cited by 167
MicroRNA Regulation of Cancer Stem Cells and Therapeutic Implications
DeSano, J. T., & Xu, L. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9147-7 · Cited by 163
Pancreatic cancer stem cells and EMT in drug resistance and metastasis.
Sarkar, F. H., Li, Y., Wang, Z., & Kong, D. (2009) · PubMed · Cited by 162
Self-citationKong, D., Wang, Z., Sarkar, S. H., Li, Y., Banerjee, S., Saliganan, A. D., Kim, H.-R. C., Cher, M. L., & Sarkar, F. H. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1076 · Cited by 160
Self-citationCross-talk between miRNA and Notch signaling pathways in tumor development and progression
Wang, Z., Li, Y., Kong, D., Ahmad, A., Banerjee, S., & Sarkar, F. H. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.11.012 · Cited by 144
Self-citationGrudzien, P., Lo, S. S., Albain, K. S., Robinson, P. A., Rajan, P. B., Strack, P. R., Golde, T. E., Miele, L., & Foreman, K. E. (2010) · PubMed · Cited by 143
Self-citationMicroRNAs in the Search for Understanding Human Diseases
Perera, R. J., & Ray, A. (2007) · BioDrugs · doi:10.2165/00063030-200721020-00004 · Cited by 133
Exploitation of the Notch signaling pathway as a novel target for cancer therapy.
Wang, Z. P., Li, Y., Banerjee, S., & Sarkar, F. H. (2008) · PubMed · Cited by 110
Self-citationEffects of Recombinant Erythropoietin on Breast Cancer-Initiating Cells
Phillips, T. M., Kim, K., Vlashi, E., McBride, W. H., & Pajonk, F. (2007) · Neoplasia · doi:10.1593/neo.07694 · Cited by 75
Billottet, C., Tuefferd, M., Gentien, D., Rapinat, A., Thiery, J. P., Broët, P., & Jouanneau, J. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21667 · Cited by 71
Pancreatic cancer stem cells: new understanding of tumorigenesis, clinical implications
Ischenko, I., Seeliger, H., Kleespies, A., Angele, M. K., Eichhorn, M., Jauch, K., & Bruns, C. J. (2009) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-009-0502-z · Cited by 53
Cited by
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
Dongre, A., & Weinberg, R. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0080-4 · Cited by 3,876
Bao, B., Wang, Z., Ali, S., Ahmad, A., Azmi, A. S., Sarkar, S. H., Banerjee, S., Kong, D., Li, Y., Thakur, S., et al. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0299 · Cited by 337
Self-citationBailey, J. M., Alsina, J., Rasheed, Z. A., McAllister, F. M., Fu, Y., Plentz, R., Zhang, H., Pasricha, P. J., Bardeesy, N., Matsui, W., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.09.050 · Cited by 312
Bao, B., Ali, S., Banerjee, S., Wang, Z., Logna, F., Azmi, A. S., Kong, D., Ahmad, A., Li, Y., Padhye, S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2182 · Cited by 297
Self-citationThe Notch signaling pathway as a mediator of tumor survival
Capaccione, K. M., & Pine, S. R. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt127 · Cited by 296
Metadata
- Authors
- Bao, B., Wang, Z., Ali, S., Kong, D., Li, Y., Ahmad, A., Banerjee, S., Azmi, A. S., Miele, L., & Sarkar, F. H.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2011-08
- Volume
- 307
- Issue
- 1
- Pages
- 26-36
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2097739264
- Cited by
- 281
- References
- 50
- FWCI
- 18.47
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.